Business Description
YIFAN PHARMACEUTICAL CO LTD
ISIN : CNE000001K65
Share Class Description:
SZSE:002019: Class ACompare
Compare
Traded in other countries / regions
002019.China IPO Date
2004-07-13Description
YIFAN PHARMACEUTICAL CO LTD is a China-based company engaged in pharmaceutical innovation and manufacturing. The company focuses its activities on key areas like macromolecular biologics, high-value pharmaceuticals, and differentiated traditional Chinese medicines. The products of the company are F-627 for Neutropenia and Parkinson's disease, F-652 for acute alcoholic hepatitis, GvHD and acute pancreatitis and F-899 for growth deficiency. The company's products are sold in China and internationally.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.42 | |||||
| Equity-to-Asset | 0.71 | |||||
| Debt-to-Equity | 0.24 | |||||
| Debt-to-EBITDA | -2.94 | |||||
| Interest Coverage | 3.99 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 3.61 | |||||
| Beneish M-Score | -2.8 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -9 | |||||
| 3-Year Book Growth Rate | -0.4 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 88.79 | |||||
| 9-Day RSI | 78.57 | |||||
| 14-Day RSI | 70.23 | |||||
| 6-1 Month Momentum % | -9.13 | |||||
| 12-1 Month Momentum % | -23.21 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.43 | |||||
| Quick Ratio | 1.03 | |||||
| Cash Ratio | 0.34 | |||||
| Days Inventory | 150.24 | |||||
| Days Sales Outstanding | 91.17 | |||||
| Days Payable | 60.76 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 0.2 | |||||
| Shareholder Yield % | 2.48 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 47.5 | |||||
| Operating Margin % | 6.42 | |||||
| Net Margin % | -10.54 | |||||
| FCF Margin % | 0.25 | |||||
| ROE % | -5.4 | |||||
| ROA % | -3.86 | |||||
| ROIC % | 2.97 | |||||
| ROC (Joel Greenblatt) % | -22.78 | |||||
| ROCE % | -6.84 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio without NRI | 33.83 | |||||
| Shiller PE Ratio | 25.34 | |||||
| PS Ratio | 3.58 | |||||
| PB Ratio | 1.9 | |||||
| Price-to-Tangible-Book | 5.17 | |||||
| Price-to-Free-Cash-Flow | 1306 | |||||
| Price-to-Operating-Cash-Flow | 30.16 | |||||
| EV-to-EBIT | -25.14 | |||||
| EV-to-EBITDA | -25.14 | |||||
| EV-to-Revenue | 3.86 | |||||
| EV-to-FCF | 1549.92 | |||||
| Price-to-Projected-FCF | 2.15 | |||||
| Price-to-Median-PS-Value | 0.81 | |||||
| Price-to-Graham-Number | 2.79 | |||||
| Price-to-Net-Current-Asset-Value | 100.46 | |||||
| Earnings Yield (Greenblatt) % | -3.98 | |||||
| FCF Yield % | 0.07 | |||||
| Forward Rate of Return (Yacktman) % | -37.34 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
YIFAN PHARMACEUTICAL CO LTD Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 4,455.544 | ||
| EPS (TTM) (Â¥) | -0.383 | ||
| Beta | 1.93 | ||
| Volatility % | 47.68 | ||
| 14-Day RSI | 70.23 | ||
| 14-Day ATR (Â¥) | 0.455291 | ||
| 20-Day SMA (Â¥) | 11.4705 | ||
| 12-1 Month Momentum % | -23.21 | ||
| 52-Week Range (Â¥) | 9.11 - 16.86 | ||
| Shares Outstanding (Mil) | 1,226.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
YIFAN PHARMACEUTICAL CO LTD Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
YIFAN PHARMACEUTICAL CO LTD Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
YIFAN PHARMACEUTICAL CO LTD Frequently Asked Questions
What is YIFAN PHARMACEUTICAL CO LTD(SZSE:002019)'s stock price today?
The current price of SZSE:002019 is ¥13.06. The 52 week high of SZSE:002019 is ¥16.86 and 52 week low is ¥9.11.
When is next earnings date of YIFAN PHARMACEUTICAL CO LTD(SZSE:002019)?
The next earnings date of YIFAN PHARMACEUTICAL CO LTD(SZSE:002019) is .
Does YIFAN PHARMACEUTICAL CO LTD(SZSE:002019) pay dividends? If so, how much?
YIFAN PHARMACEUTICAL CO LTD(SZSE:002019) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers